Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Noma is a prominent line of pediatric nutritional supplements developed and marketed by the South Korean company Sam-A Pharmaceutical. The product series is specifically formulated to meet the nutritional requirements of growing children and infants, providing a balanced combination of essential vitamins and minerals. The Noma product line includes various formulations such as Noma Gold and Noma F, which are typically available as chewable tablets or granules to enhance pediatric compliance. These supplements contain a comprehensive blend of nutrients, including Vitamin A, B-complex (B1, B2, B6, B12), C, D, and E, along with minerals such as calcium and magnesium. Noma is indicated for the prevention and treatment of vitamin and mineral deficiencies, supporting bone development, immune function, and overall physical growth in the pediatric population.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Noma.